CN Patent

CN104163794A — 2-氨基芳环类血管内皮生长因子受体(vegfr)抑制剂及其制备方法和用途

Assigned to China Pharmaceutical University · Expires 2014-11-26 · 11y expired

What this patent protects

本发明涉及一种结构新颖的如式(I)所示的2-氨基吡啶类化合物、其药用盐、其前药、其水合物或溶剂合物，也涉及所述化合物的制备方法、包含治疗有效剂量的所述化合物的药物组合物，以及其作为蛋白酪氨酸激酶抑制剂，尤其是作为血管内皮生长因子-2-Vascular Endothelial Growth Factor Receptor2，VEGFR-2，Kinase Domain Receptor，KDR)抑制剂，在制备预防和／或治疗VEGFR-2异常相关疾病的药物中的用途。

USPTO Abstract

本发明涉及一种结构新颖的如式(I)所示的2-氨基吡啶类化合物、其药用盐、其前药、其水合物或溶剂合物，也涉及所述化合物的制备方法、包含治疗有效剂量的所述化合物的药物组合物，以及其作为蛋白酪氨酸激酶抑制剂，尤其是作为血管内皮生长因子-2-Vascular Endothelial Growth Factor Receptor2，VEGFR-2，Kinase Domain Receptor，KDR)抑制剂，在制备预防和／或治疗VEGFR-2异常相关疾病的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104163794A
Jurisdiction
CN
Classification
—
Expires
2014-11-26
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.